| Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer (NCT07229339) | Jonsson Comprehensive Cancer Center | 2027-06-01 |
| Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer (NCT07634601) | Jonsson Comprehensive Cancer Center | 2026-12-18 |
| PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma (NCT06448286) | Jonsson Comprehensive Cancer Center | 2026-12-01 |
| Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer (NCT07716735) | Jonsson Comprehensive Cancer Center | 2026-12-01 |
| A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer (NCT07032701) | Jonsson Comprehensive Cancer Center | 2026-12-01 |
| A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study (NCT07517211) | Jonsson Comprehensive Cancer Center | 2026-12-01 |
| Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia (NCT07468916) | Jonsson Comprehensive Cancer Center | 2026-09-29 |
| STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection (NCT07612293) | Jonsson Comprehensive Cancer Center | 2026-09-02 |
| Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial (NCT07439484) | Jonsson Comprehensive Cancer Center | 2026-09-01 |
| Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial (NCT07671768) | Jonsson Comprehensive Cancer Center | 2026-07-01 |
| RAD ONC FREEDOM Oncology Pain (NCT07605546) | Jonsson Comprehensive Cancer Center | 2026-06-09 |
| AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer (NCT07619313) | Jonsson Comprehensive Cancer Center | 2026-06-01 |
| Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer (NCT07468903) | Jonsson Comprehensive Cancer Center | 2026-05-11 |
| Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial (NCT07191717) | Jonsson Comprehensive Cancer Center | 2026-04-30 |
| Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer (NCT07323641) | Jonsson Comprehensive Cancer Center | 2026-02-19 |
| Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies (NCT07310004) | Jonsson Comprehensive Cancer Center | 2026-01-20 |
| Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment (NCT07293585) | Jonsson Comprehensive Cancer Center | 2025-12-16 |
| Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma (NCT07150715) | Jonsson Comprehensive Cancer Center | 2025-12-12 |
| Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma (NCT07235280) | Jonsson Comprehensive Cancer Center | 2025-12-02 |
| Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial (NCT07276438) | Jonsson Comprehensive Cancer Center | 2025-12-01 |
| Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial (NCT07164027) | Jonsson Comprehensive Cancer Center | 2025-11-14 |
| Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients (NCT07461948) | Jonsson Comprehensive Cancer Center | 2025-10-27 |
| A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients (NCT06934239) | Jonsson Comprehensive Cancer Center | 2025-10-15 |
| An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. (NCT07185165) | Jonsson Comprehensive Cancer Center | 2025-10-09 |
| Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis (NCT07339085) | Jonsson Comprehensive Cancer Center | 2025-08-28 |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers (NCT07118176) | Jonsson Comprehensive Cancer Center | 2025-08-01 |
| External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer (NCT06543576) | Jonsson Comprehensive Cancer Center | 2025-07-29 |
| ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial (NCT07089641) | Jonsson Comprehensive Cancer Center | 2025-07-28 |
| Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity (NCT07077239) | Jonsson Comprehensive Cancer Center | 2025-07-17 |
| Ivonescimab for the Treatment of Thymic Cancer (NCT06980077) | Jonsson Comprehensive Cancer Center | 2025-07-15 |
| Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial (NCT06995053) | Jonsson Comprehensive Cancer Center | 2025-06-27 |
| Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) (NCT06810778) | Jonsson Comprehensive Cancer Center | 2025-05-02 |
| A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers (NCT06568016) | Jonsson Comprehensive Cancer Center | 2025-04-22 |
| Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms (NCT06788938) | Jonsson Comprehensive Cancer Center | 2025-03-21 |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial (NCT06432036) | Jonsson Comprehensive Cancer Center | 2024-12-26 |
| Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors (NCT06650163) | Jonsson Comprehensive Cancer Center | 2024-12-05 |
| Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant (NCT05457959) | Jonsson Comprehensive Cancer Center | 2024-12-01 |
| Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) (NCT06572423) | Jonsson Comprehensive Cancer Center | 2024-10-25 |
| An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer (NCT06447103) | Jonsson Comprehensive Cancer Center | 2024-08-06 |
| Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia (NCT05720988) | Jonsson Comprehensive Cancer Center | 2024-08-03 |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) (NCT06216249) | Jonsson Comprehensive Cancer Center | 2024-08-01 |
| Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers (NCT06538337) | Jonsson Comprehensive Cancer Center | 2024-07-24 |
| Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors (NCT06113016) | Jonsson Comprehensive Cancer Center | 2024-07-23 |
| Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer (NCT05775471) | Jonsson Comprehensive Cancer Center | 2024-06-24 |
| A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma (NCT06342908) | Jonsson Comprehensive Cancer Center | 2024-06-14 |
| Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial) (NCT06436612) | Jonsson Comprehensive Cancer Center | 2024-05-30 |
| Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy (NCT05398302) | Jonsson Comprehensive Cancer Center | 2024-04-26 |
| An Organoid-based Functional Precision Medicine Trial in Osteosarcoma (NCT06064682) | Jonsson Comprehensive Cancer Center | 2024-02-12 |
| Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer (NCT06387173) | Jonsson Comprehensive Cancer Center | 2024-01-04 |
| Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps (NCT06376565) | Jonsson Comprehensive Cancer Center | 2023-11-08 |
| Psychoeducation for Uveal Melanoma (NCT06075589) | Jonsson Comprehensive Cancer Center | 2023-11-07 |
| Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) (NCT05523700) | Jonsson Comprehensive Cancer Center | 2023-10-17 |
| Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance (NCT06047509) | Jonsson Comprehensive Cancer Center | 2023-09-14 |
| Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells (NCT06059690) | Jonsson Comprehensive Cancer Center | 2023-09-06 |
| Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease (NCT04280471) | Jonsson Comprehensive Cancer Center | 2023-09-01 |
| Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer (NCT05841706) | Jonsson Comprehensive Cancer Center | 2023-08-10 |
| Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants (NCT05978128) | Jonsson Comprehensive Cancer Center | 2023-07-28 |
| Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors (NCT05595499) | Jonsson Comprehensive Cancer Center | 2023-03-27 |
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma (NCT05688215) | Jonsson Comprehensive Cancer Center | 2023-03-07 |
| Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma (NCT05256641) | Jonsson Comprehensive Cancer Center | 2023-01-23 |
| An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer (NCT05558904) | Jonsson Comprehensive Cancer Center | 2023-01-19 |
| Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer (NCT06090916) | Jonsson Comprehensive Cancer Center | 2023-01-17 |
| 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study (NCT05496959) | Jonsson Comprehensive Cancer Center | 2022-09-02 |
| Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma (NCT06090903) | Jonsson Comprehensive Cancer Center | 2022-04-14 |
| Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer (NCT05319873) | Jonsson Comprehensive Cancer Center | 2022-04-07 |
| Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy (NCT05115760) | Jonsson Comprehensive Cancer Center | 2022-04-05 |
| Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy (NCT05160597) | Jonsson Comprehensive Cancer Center | 2022-01-13 |
| Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma (NCT04429204) | Jonsson Comprehensive Cancer Center | 2021-12-01 |
| Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (NCT04603365) | Jonsson Comprehensive Cancer Center | 2021-10-18 |
| Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors (NCT04290897) | Jonsson Comprehensive Cancer Center | 2021-09-29 |
| Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma (NCT05045027) | Jonsson Comprehensive Cancer Center | 2021-09-01 |
| High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma (NCT04945642) | Jonsson Comprehensive Cancer Center | 2021-08-20 |
| A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors (NCT05000359) | Jonsson Comprehensive Cancer Center | 2021-07-12 |
| Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia (NCT04712851) | Jonsson Comprehensive Cancer Center | 2021-06-30 |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy (NCT04915508) | Jonsson Comprehensive Cancer Center | 2021-06-23 |
| 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy (NCT04928820) | Jonsson Comprehensive Cancer Center | 2021-06-16 |
| ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma (NCT04854044) | Jonsson Comprehensive Cancer Center | 2021-05-01 |
| 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer (NCT04857502) | Jonsson Comprehensive Cancer Center | 2021-04-27 |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (NCT04705025) | Jonsson Comprehensive Cancer Center | 2021-04-08 |
| Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification (NCT04765150) | Jonsson Comprehensive Cancer Center | 2021-04-01 |
| Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer (NCT03902951) | Jonsson Comprehensive Cancer Center | 2021-03-17 |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer (NCT04703101) | Jonsson Comprehensive Cancer Center | 2021-02-11 |
| Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer (NCT04285671) | Jonsson Comprehensive Cancer Center | 2021-01-29 |
| Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma (NCT04375527) | Jonsson Comprehensive Cancer Center | 2020-12-03 |
| Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial (NCT04624256) | Jonsson Comprehensive Cancer Center | 2020-11-10 |
| Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy (NCT04299620) | Jonsson Comprehensive Cancer Center | 2020-10-21 |
| Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer (NCT04469764) | Jonsson Comprehensive Cancer Center | 2020-10-16 |
| Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma (NCT04420975) | Jonsson Comprehensive Cancer Center | 2020-10-14 |
| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer (NCT04553770) | Jonsson Comprehensive Cancer Center | 2020-10-09 |
| Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation (NCT04457232) | Jonsson Comprehensive Cancer Center | 2020-09-09 |
| 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma (NCT04457258) | Jonsson Comprehensive Cancer Center | 2020-09-08 |
| Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers (NCT04459273) | Jonsson Comprehensive Cancer Center | 2020-08-27 |
| Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (NCT04457245) | Jonsson Comprehensive Cancer Center | 2020-08-14 |
| Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies (NCT04395079) | Jonsson Comprehensive Cancer Center | 2020-08-07 |
| Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer (NCT04473781) | Jonsson Comprehensive Cancer Center | 2020-07-16 |
| Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI (NCT04460495) | Jonsson Comprehensive Cancer Center | 2020-07-07 |
| A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant (NCT04453072) | Jonsson Comprehensive Cancer Center | 2020-07-01 |
| Role of Children in Transmission of COVID-19 to Immunocompromised Patients (NCT04407546) | Jonsson Comprehensive Cancer Center | 2020-05-27 |
| Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma (NCT04299113) | Jonsson Comprehensive Cancer Center | 2020-05-14 |
| Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer (NCT04279561) | Jonsson Comprehensive Cancer Center | 2020-04-16 |